|
1
|
Heidelberger C, Chaudhuri NK, Danneburg P,
et al: Fluorinated pyrimidines, a new class of tumour-inhibitory
compounds. Nature. 179:663–666. 1957. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cai TB, Tang X, Nagorski J, Brauschweiger
PG and Wang PG: Synthesis and cytotoxicity of
5-fluorouracil/diazeniumdiolate conjugates. Bioorg Med Chem.
11:4971–4975. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
No authors listed. Efficacy of adjuvant
fluorouracil and folinic acid in colon cancer. International
Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT)
investigators. Lancet. 345:939–944. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin FH, Lee YH, Jian CH, Wong JM, Shieh MJ
and Wang CY: A study of purified montmorillonite intercalated with
5-fluorouracil as drug carrier. Biomaterials. 23:1981–1987. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bleiberg H: Colorectal cancer - is there
an alternative to 5-FU? Eur J Cancer. 33:536–541. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Riley SA and Turnberg LA: Sulphasalazine
and the aminosalicylates in the treatment of inflammatory bowel
disease. Q J Med. 75:551–562. 1990.PubMed/NCBI
|
|
7
|
Bartalsky A: Salicylazobenzoic acid in
ulcerative colitis. Lancet. 319:9601982. View Article : Google Scholar
|
|
8
|
Ashford M, Fell J, Attwood D, Sharma H and
Woodhead P: In vitro investigation into the suitability of pH
dependent polymer for colonic targeting. Int J Pharm. 95:193–199.
1993. View Article : Google Scholar
|
|
9
|
Marvola M, Nykänen P, Rautio S, Isonen N
and Autere AM: Enteric polymers as binders and coating materials in
multiple-unit site-specific drug delivery systems. Eur J Pharm Sci.
7:259–267. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gazzaniga A, Busetti C, Sangali ME and
Giordana ME: Time-dependent oral delivery system for colonic
targeting system for the colon targeting. STP Pharma Sci. 5:83–88.
1995.
|
|
11
|
Gazzaniga A, Iamartino P, Maffione G and
Sangal ME: Oral delayed release system system for colonic specific
delivery. Int J Pharm. 108:77–83. 1994. View Article : Google Scholar
|
|
12
|
Malet-Martino M and Martino R: Clinical
studies of three oral prodrugs of 5-fluorouracil (capecitabine,
UFT, S-1): a review. Oncologist. 7:288–323. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Malet-Martino M, Jolimaitre P and Martino
R: The prodrugs of 5-fluorouracil. Curr Med Chem Anticancer Agents.
2:267–310. 2002. View Article : Google Scholar
|
|
14
|
Haller DG: An overview of adjuvant therapy
for colorectal. Eur J Cancer. 31A:1255–1263. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bajetta E, Di Bartolomeo M, Somma L, Del
Vecchio M, Artale S, Zunino F, Bignami P, Magnani E and Buzzoni R:
Doxifluridine in colorectal cancer patients resistant to
5-fluorouracil (5-FU) containing regimens. Eur J Cancer.
33:687–690. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hovgaard L and Brondsted H: Dextran
hydrogels for colon-specific drug delivery. J Control Release.
36:159–166. 1995. View Article : Google Scholar
|
|
17
|
Watts PJ and Lllum L: Colonic drug
delivery. Drug Dev Ind Pharm. 23:893–913. 1997. View Article : Google Scholar
|
|
18
|
Saranya N, Moorthi A, Saravanan S, Devi MP
and Selvamurugan N: Chitosan and its derivatives for gene delivery.
Int J Biol Macromol. 48:234–238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee KY, Kwon IC, Kim YH, Jo WH and Jeong
SY: Preparation of chitosan self-aggregates as a gene delivery
system. J Control Release. 51:213–220. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hejazi R and Amiji M: Chitosan-based
gastrointestinal delivery system. J Control Release. 89:151–165.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mansouri S, Lavigne P, Corsi K, Benderdour
M, Beaumont E and Fernandes JC: Chitosan-DNA nanoparticles as
non-viral vectors in gene therapy: strategies to improve
transfection efficacy. Eur J Pharm Biopharm. 57:1–8. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dang JM and Leong KW: Natural polymers for
gene delivery and tissue engineering. Adv Drug Deliv Rev.
58:487–499. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chung YC, Kuo CL and Chen CC: Preparation
and important functional properties of water-soluble chitosan
produced through Maillard reaction. Bioresour Technol.
96:1473–1482. 2005. View Article : Google Scholar
|
|
24
|
Liu WG, Zhang X, Sun SJ, Sun GJ, Yao KD,
Liang DC, Guo G and Zhang JY: N-alkylated chitosan as a potential
nonviral vector for gene transfection. Bioconjug Chem. 14:782–789.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mao S, Shuai X, Unger F, Wittmar M, Xie X
and Kissel T: Synthesis, characterization and cytotoxicity of
poly(ethylene glycol)-graft-trimethyl chitosan block copolymers.
Biomaterials. 26:6343–6356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gref R, Lück M, Quellec P, Marchand M,
Dellacherie E, Harnisch S, et al: ‘Stealth’ corona-core
nanoparticles surface modified by polyethylene glycol (PEG):
influences of the corona (PEG chain length and surface density) and
of the core composition on phagocytic uptake and plasma protein
adsorption. Colloids Surf B Biointerfaces. 18:301–313. 2000.
|
|
27
|
Kircheis R, Schüller S, Brunner S, Ogris
M, Heider KH, Zauner W, et al: Polycation-based DNA complexes for
tumor-targeted gene delivery in vivo. J Gene Med. 1:111–120. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ogris M, Brunner S, Schuller S, Kircheis R
and Wagner E: PEGylated DNA/transferrin-PEI complexes: reduced
interaction with blood components, extended circulation in blood
and potential for systemic gene delivery. Gene Ther. 6:595–605.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Oupický D, Ogris M and Seymour LW:
Development of long-circulating polyelectrolyte complexes for
systemic delivery of genes. J Drug Target. 10:93–98.
2002.PubMed/NCBI
|
|
30
|
Nguyen HK, Lemieux P, Vinogradov SV,
Gebhart CL, Guérin N, Paradis G, et al: Evaluation of
polyether-polyethyleneimine graft copolymers as gene transfer
agents. Gene Ther. 7:126–138. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Choi YH, Liu F, Kim JS, Choi YK, Park JS
and Kim SW: Polyethylene glycol-grafted poly-L-lysine as polymeric
gene carrier. J Control Release. 54:39–48. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fernandez-Megia E, Novoa-Carballal R,
Quiñoá E and Riguera R: Conjugation of bioactive ligands to
PEG-grafted chitosan at the distal end of PEG. Biomacromolecules.
8:833–842. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ogris M, Walker G, Blessing T, Kircheis R,
Wolschek M and Wagner E: Tumor-targeted gene therapy: strategies
for the preparation of ligand-polyethylene
glycol-polyethylenimine/DNA complexes. J Control Release.
91:173–181. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin
KY, Wang Y, et al: Chitosan-DNA nanoparticles as gene carriers:
synthesis, characterization and transfection efficiency. J Control
Release. 70:399–421. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim TH, Nah JW, Cho MH, Park TG and Cho
CS: Receptor-mediated gene delivery into antigen presenting cells
using mannosylated chitosan/DNA nanoparticles. J Nanosci
Nanotechnol. 6:2796–2803. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hashimoto M, Morimoto M, Saimoto H,
Shigemasa Y, Yanagie H, Eriguchi M and Sato T: Gene transfer by
DNA/mannosylated chitosan complexes into mouse peritoneal
macrophages. Biotechnol Lett. 28:815–821. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wada K, Arima H, Tsutsumi T, Chihara Y,
Hattori K, Hirayama F and Uekama K: Improvement of gene delivery
mediated by mannosylated dendrimer/alpha-cyclodextrin conjugates. J
Control Release. 104:397–413. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mansouri S, Cuie Y, Winnik F, Shi Q,
Lavigne P, Benderdour M, et al: Characterization of
folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials.
27:2060–2065. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee D, Lockey R and Mohapatra S: Folate
receptor-mediated cancer cell specific gene delivery using folic
acid-conjugated oligochitosans. J Nanosci Nanotechnol. 6:2860–2866.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Murata J, Ohya Y and Ouchi T: Design of
quaternary chitosan conjugate having antennary galactose residues
as a gene delivery tool. Carbohydr Polym. 32:105–119. 1997.
View Article : Google Scholar
|
|
41
|
Gao S, Chen J, Xu X, Ding Z, Yang YH, Hua
Z and Zhang J: Galactosylated low molecular weight chitosan as DNA
carrier for hepatocyte-targeting. Int J Pharm. 255:57–68. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kim TH, Park IK, Nah JW, Choi YJ and Cho
CS: Galactosylated chitosan/DNA nanoparticles prepared using
water-soluble chitosan as a gene carrier. Biomaterials.
25:3783–3792. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hashimoto M, Morimoto M, Saimoto H,
Shigemasa Y and Sato T: Lactosylated chitosan for DNA delivery into
hepatocytes: the effect of lactosylation on the physicochemical
properties and intracellular trafficking of pDNA/chitosan
complexes. Bioconjug Chem. 17:309–316. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Weitman SD, Lark RH, Coney LR, Fort DW,
Frasca V, Zurawski VR Jr and Kamen BA: Distribution of the folate
receptor GP38 in normal and malignant cell lines and tissues.
Cancer Res. 52:3396–3401. 1992.PubMed/NCBI
|
|
45
|
Antony AC: Folate receptors. Annu Rev
Nutr. 16:501–521. 1996. View Article : Google Scholar
|
|
46
|
Lee RJ and Low PS: Delivery of liposomes
into cultured KB cells via folate receptor-mediated endocytosis. J
Biol Chem. 269:3198–3204. 1994.PubMed/NCBI
|
|
47
|
Lee RJ and Low PS: Folate-mediated tumor
cell targeting of liposome-entrapped doxorubicin in vitro. Biochem
Biophys Acta. 1233:134–144. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ross JF, Chaudhuri PK and Ratnam M:
Differential regulation of folate receptor isoforms in normal and
malignant tissues in vivo and in established cell lines.
Physiologic and clinical implications. Cancer. 73:2432–2443. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kamaly N, Kalber T, Thanou M, Bell JD and
Miller AD: Folate receptor targeted bimodal liposomes for tumor
magnetic resonance imaging. Bioconjug Chem. 20:648–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zheng Y, Cai Z, Song X, Chen Q, Bi Y, Li Y
and Hou S: Preparation and characterization of folate conjugated
N-trimethyl chitosan nanoparticles as protein carrier targeting
folate receptor: in vitro studies. J Drug Target. 17:294–303. 2009.
View Article : Google Scholar
|
|
51
|
Hwa Kim S, Hoon Jeong J, Chul Cho K, Wan
Kim S and Gwan Park T: Target-specific gene silencing by siRNA
plasmid DNA complexed with folate-modified poly(ethylenimine). J
Control Release. 104:223–232. 2005.PubMed/NCBI
|
|
52
|
Hwa Kim S, Hoon Jeong J, Co Joe and Gwan
Park T: Folate receptor mediated intracellular protein delivery
using PLL-PEG-FOL conjugate. J Control Release. 103:625–634.
2005.PubMed/NCBI
|
|
53
|
Liang B, He ML, Xiao ZP, et al: Synthesis
and characterization of folate-PEG-grafted-hyperbranched-PEI for
tumor-targeted gene delivery. Biochem Biophys Res Commun.
367:874–880. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Benns JM, Mahato RI and Kim SW:
Optimization of factors influencing the transfection efficiency of
folate-PEG-folate-graft-polyethylenimine. J Control Release.
79:255–269. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Benns JM, Maheshwari A, Furgeson DY,
Mahato RI and Kim SW:
Folate-PEG-folate-graft-polyethylenimine-based gene delivery. J
Drug Target. 9:123–139. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Cheng H, Zhu JL, Zeng X, Jing Y, Zhang XZ
and Zhuo RX: Targeted gene delivery mediated by
folate-polyethylenimine-block-poly(ethylene glycol) with receptor
selectivity. Bioconjug Chem. 20:481–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kim SH, Mok H, Jeong JH, Kim SW and Park
TG: Comparative evaluation of target-specific GFP gene silencing
efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid
complexed with PEI-PEG-FOL conjugate. Bioconjug Chem. 17:241–244.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Corsi K, Chellat F, Yahia L and Fernandes
JC: Mesenchymal stem cells, MG63 and HEK293 transfection using
chitosan-DNA nanoparticles. Biomaterials. 24:1255–1264. 2003.
View Article : Google Scholar : PubMed/NCBI
|
